Digestive Health
    Procedures

    GLP-1 and Colonoscopy Prep: Essential Patient Guidance

    If you are on a GLP-1 medication and have a colonoscopy scheduled, there are important steps to take for a safe and effective procedure. Here is what you and your providers need to coordinate.

    Published: April 3, 20269 min read

    Important: This article provides general guidance. Always follow the specific instructions from your gastroenterologist and prescribing provider regarding medication management before any procedure.

    Colonoscopies are a critical preventive health screening, and being on a GLP-1 medication should not prevent you from getting one. However, GLP-1 medications require special consideration before sedated procedures due to their effects on gastric emptying.

    Why GLP-1 Medications Matter for Colonoscopy

    The core concern is aspiration risk. Semaglutide and tirzepatide significantly slow gastric emptying — meaning food and liquids remain in your stomach longer than normal. During sedation, if stomach contents reflux into the esophagus, they can be inhaled into the lungs (aspiration), potentially causing aspiration pneumonia or other serious complications.

    Current Guidelines

    Pre-Procedure Medication Management

    • Weekly GLP-1 injectables (semaglutide, tirzepatide): Hold for 7 days before the procedure (skip the dose that falls within one week of the procedure date)
    • Daily GLP-1 medications: Hold for 24 hours before the procedure
    • Tell all your providers: Inform both your gastroenterologist and your GLP-1 prescriber about the procedure
    • If you forgot to hold your dose: Contact your gastroenterologist — they may postpone the procedure or require an extended clear-liquid diet

    Prep Modifications for GLP-1 Patients

    Because GLP-1 medications slow digestive transit, standard colonoscopy prep may need adjustments:

    • Extended clear liquid diet: Consider starting clear liquids 48 hours before (instead of the standard 24 hours)
    • Split-dose prep: If not already planned, request a split-dose prep protocol for better cleansing
    • Additional prep: Your gastroenterologist may prescribe extra prep solution or add a prokinetic agent
    • Earlier start time: Begin prep earlier in the day to allow more time for effect

    Day of Procedure Checklist

    • Confirm you have held your GLP-1 medication as directed
    • Follow all clear-liquid and fasting instructions precisely
    • Inform the anesthesiologist or sedation provider that you take a GLP-1 medication
    • Mention when you took your last dose
    • Report any symptoms of retained food (feeling full, bloating, nausea)

    After the Procedure

    Once your colonoscopy is complete and you are tolerating food and liquids normally, most patients can resume their GLP-1 medication at their next scheduled dose. If you held a weekly injection, you may restart on your usual injection day or as directed by your provider.

    Frequently Asked Questions

    Should I stop my GLP-1 medication before a colonoscopy?

    The American Society of Anesthesiologists recommends holding GLP-1 medications before procedures requiring sedation due to aspiration risk from retained gastric contents. For weekly injectables like semaglutide and tirzepatide, guidelines suggest holding the dose for one week before the procedure. Always follow your specific provider's instructions.

    Does GLP-1 medication affect the quality of colonoscopy prep?

    Slowed gastric emptying can potentially affect how well the prep solution moves through your system. Some patients on GLP-1 medications report that standard prep takes longer to work or is less effective. Your gastroenterologist may recommend an extended or split-dose prep to ensure adequate colon cleansing.

    Is there an aspiration risk during colonoscopy while on GLP-1 medications?

    Yes, this is the primary concern. GLP-1 medications can leave food in the stomach for longer than normal, which increases the risk of aspiration (inhaling stomach contents into the lungs) during sedation. This is why most guidelines recommend holding the medication before the procedure.

    When can I restart my GLP-1 medication after a colonoscopy?

    Most providers say you can resume your GLP-1 medication the day after your colonoscopy, once you are eating and drinking normally. If your procedure was routine with no complications, restarting at your usual time is typically fine. Check with your prescribing provider and gastroenterologist.

    Comprehensive Care with Trimi

    Our medical team coordinates with your other providers for safe treatment. Semaglutide from $99/mo, tirzepatide from $125/mo, plus retatrutide.

    View Treatments

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    How do I prep for endoscopy on GLP-1?

    GLP-1 receptor agonist medications (semaglutide, tirzepatide) require special preparation before endoscopy due to their mechanism of delayed gastric emptying — food and gastric contents stay in the stomach longer than normal, which significantly increases aspiration risk during anesthesia or sedation. Per anesthesia and endoscopy society guidelines as of May 2026 (American Society of Anesthesiologists and various GI societies have issued recommendations), the standard recommendation is to hold GLP-1 dose 1-2 weeks before elective endoscopy to allow the stomach to empty normally before the procedure. Specific protocols by procedure type: routine upper endoscopy (EGD): hold weekly GLP-1 ≥7 days before procedure, typically 10-14 days; colonoscopy: same recommendation, plus follow standard bowel prep; bariatric or upper GI surgery: longer hold of 2-3 weeks may be required. If you have a recent GLP-1 dose and can't postpone the procedure: extended NPO (nothing-by-mouth) fasting period of 12-18+ hours may be required (vs standard 8 hours); some cases require procedure postponement; some anesthesiologists may use additional anesthesia precautions (rapid sequence induction, full stomach precautions). Critical: communicate ALL medications including GLP-1 to your medical team during pre-procedure assessment — don't assume they know. Provide: medication name (semaglutide or tirzepatide), dose, last injection date, prescribing clinician contact. Many anesthesia teams will postpone elective procedures rather than risk aspiration in patients on recent GLP-1 doses. Consult your endoscopist and anesthesiologist for specific timing guidance — protocols vary by institution, procedure complexity, and patient-specific factors. Trimi via Beluga Health 50-state network can coordinate dose timing around scheduled procedures; communicate any upcoming procedures during clinician consultation. Resume GLP-1 after procedure recovery; standard timing is 1-2 days post-procedure once gastric function has returned to normal.

    Hold GLP-1 1-2 weeks before elective endoscopy.
    Communicate medication to anesthesia team in pre-procedure assessment.
    Resume 1-2 days post-procedure after recovery.

    Key Takeaways

    • GLP-1 medications (semaglutide, tirzepatide) require special preparation before endoscopy due to delayed gastric emptying — increases aspiration risk during anesthesia.
    • Anesthesia recommendations May 2026: hold GLP-1 dose 1-2 weeks before elective endoscopy to allow stomach to empty normally.
    • If recent dose: extended fasting (NPO 12-18+ hours) may be required; some cases postpone procedure.
    • Consult endoscopist + anesthesiologist about specific timing — protocols vary by institution and procedure type.
    • Communicate ALL medications including GLP-1 to medical team during pre-procedure assessment.

    Medically Reviewed

    DMR

    Dr. Michael Rodriguez

    MD, FACP, Board Certified in Internal Medicine

    Internal Medicine & Weight Management

    Last reviewed: December 19, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Dr. Michael Rodriguez, MD, FACP, Board Certified in Internal Medicine

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.

    Outcome: 4-day delivery; 3 vials for first 3 months; price + convenience verdict positive

    Really great customer service! Fast shipment.

    Outcome: Fast shipment

    Amy KeithFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Eli Lilly and Company (2025). Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.Read Study
    2. Novo Nordisk (2025). Wegovy (semaglutide) prescribing information. U.S. Food and Drug Administration.Read Study
    3. The Endocrine Society (2024). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism.Read Study
    4. Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2206038

    Was this article helpful?

    Keep Reading

    Complete guide to semaglutide 1.7mg dosing. Learn about expected weight loss results, side effects at this higher dose, and how to decide between staying at 1.7mg or advancing to 2.4mg.

    Buy compounded semaglutide online in Texas for $99/month. Learn about Texas telehealth laws, compounding pharmacy access, and how to start affordable GLP-1 weight loss treatment.

    Retatrutide and fertility: learn how weight loss improves reproductive health, when to stop medication before conception, pregnancy safety, and fertility planning with GLP-1 treatment.

    Complete guide to Foundayo (orforglipron) for weight loss. FDA-approved results, how much weight you can lose, eligibility, timeline, and how it compares to other GLP-1 options.

    Start your GLP-1 journey — from $99/mo

    Get Started